{"entity":{"type":"insider","cik":"0001695076","url":"/insider/0001695076","json_url":"/insider/0001695076.json","name":"Pivotal bioVenture Partners Fund I, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2018-10-02","last":"2023-08-03","span_basis":"filed_date"},"name_variants":[{"name":"Pivotal bioVenture Partners Fund I, L.P.","source":"filing","n_filings":5,"first_seen":"2018-10-02","last_seen":"2023-08-03"}],"transactions":[{"id":8530351,"accession":"0000950170-23-038272","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-038272","line_url":"/filing/0000950170-23-038272#line-2","is_derivative":false,"issuer_cik":"0001693011","issuer_name":"Inozyme Pharma, Inc.","issuer_ticker":"INZY","issuer_name_source":null,"issuer_url":"/issuer/0001693011","owner_cik":null,"owner_name":"Pivotal bioVenture Partners Fund I G.P., L.P.; Pivotal bioVenture Partners Fund I U.G.P. Ltd; Pivotal bioVenture Partners Fund I, L.P.","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":714285.0,"shares_display":"714,285","price_per_share":4.8,"price_display":"4.80","price_state":"stated","total_value":3428568.0,"total_display":"3,428,568.00","shares_owned_after":1571741.0,"shares_owned_after_display":"1,571,741","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-01","filed_date":"2023-08-03","scope":"insider"},{"id":8530347,"accession":"0000950170-23-038272","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-038272","line_url":"/filing/0000950170-23-038272#line-1","is_derivative":false,"issuer_cik":"0001693011","issuer_name":"Inozyme Pharma, Inc.","issuer_ticker":"INZY","issuer_name_source":null,"issuer_url":"/issuer/0001693011","owner_cik":null,"owner_name":"Pivotal bioVenture Partners Fund I G.P., L.P.; Pivotal bioVenture Partners Fund I U.G.P. Ltd; Pivotal bioVenture Partners Fund I, L.P.","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":119048.0,"shares_display":"119,048","price_per_share":4.8,"price_display":"4.80","price_state":"stated","total_value":571430.4,"total_display":"571,430.40","shares_owned_after":2923110.0,"shares_owned_after_display":"2,923,110","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-01","filed_date":"2023-08-03","scope":"insider"},{"id":6474574,"accession":"0001062993-22-010574","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-010574","line_url":"/filing/0001062993-22-010574#line-1","is_derivative":false,"issuer_cik":"0001693011","issuer_name":"Inozyme Pharma, Inc.","issuer_ticker":"INZY","issuer_name_source":null,"issuer_url":"/issuer/0001693011","owner_cik":null,"owner_name":"Pivotal bioVenture Partners Fund I U.G.P., Ltd; Pivotal bioVenture Partners Fund I, L.P.; Pivotal bioVenture Partners Fund I G.P., L.P.","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1070000.0,"shares_display":"1,070,000","price_per_share":3.69,"price_display":"3.69","price_state":"stated","total_value":3948300.0,"total_display":"3,948,300.00","shares_owned_after":2661154.0,"shares_owned_after_display":"2,661,154","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-19","filed_date":"2022-04-20","scope":"insider"},{"id":2068786,"accession":"0001012975-20-000664","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-20-000664","line_url":"/filing/0001012975-20-000664#line-2","is_derivative":false,"issuer_cik":"0001693011","issuer_name":"Inozyme Pharma, Inc.","issuer_ticker":"INZY","issuer_name_source":null,"issuer_url":"/issuer/0001693011","owner_cik":null,"owner_name":"Pivotal bioVenture Partners Fund I, L.P.; Pivotal bioVenture Partners Fund I G.P., L.P.; Pivotal bioVenture Partners Fund I U.G.P., Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":187500.0,"shares_display":"187,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","shares_owned_after":1591154.0,"shares_owned_after_display":"1,591,154","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-28","filed_date":"2020-07-28","scope":"insider"},{"id":2603867,"accession":"0001012975-20-000601","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-20-000601","line_url":"/filing/0001012975-20-000601#line-2","is_derivative":false,"issuer_cik":"0001695076","issuer_name":"Akouos, Inc.","issuer_ticker":"AKUS","issuer_name_source":null,"issuer_url":"/issuer/0001695076","owner_cik":null,"owner_name":"Pivotal bioVenture Partners Fund I G.P., L.P.; Pivotal bioVenture Partners Fund I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":294117.0,"shares_display":"294,117","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":4999989.0,"total_display":"4,999,989.00","shares_owned_after":1794088.0,"shares_owned_after_display":"1,794,088","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-30","filed_date":"2020-07-01","scope":"insider"},{"id":6727309,"accession":"0001209191-18-053537","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-053537","line_url":"/filing/0001209191-18-053537#line-3","is_derivative":false,"issuer_cik":"0001695076","issuer_name":"Entasis Therapeutics Holdings Inc.","issuer_ticker":"ETTX","issuer_name_source":null,"issuer_url":"/issuer/0001695076","owner_cik":null,"owner_name":"Pivotal bioVenture Partners Fund I, L.P.; Pivotal bioVenture Partners Fund I G.P., L.P.; Pivotal bioVenture Partners Fund I U.G.P., Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":337724.0,"shares_display":"337,724","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":5065860.0,"total_display":"5,065,860.00","shares_owned_after":1180178.0,"shares_owned_after_display":"1,180,178","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-09-28","filed_date":"2018-10-02","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001693011","name":"Inozyme Pharma, Inc.","url":"/issuer/0001693011","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2020-07-28","last_seen":"2023-08-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001722271","name":"Akouos, Inc.","url":"/issuer/0001722271","role":"Ten percent owner","n_filings":1,"first_seen":"2020-07-01","last_seen":"2020-07-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001724344","name":"Entasis Therapeutics Holdings Inc.","url":"/issuer/0001724344","role":"Ten percent owner","n_filings":1,"first_seen":"2018-10-02","last_seen":"2018-10-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001695076","retrieved_at":"2026-08-21T07:27:18+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}